http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6affd0500d4da9bb4a53aa3941a0e4ed
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Giobbie-Hurder |
| name | Anita Giobbie-Hurder |
| given-name | Anita |
| organization-name | F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute; Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital; Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA; Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and... International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 3Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 5Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. 4Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. agiohur@jimmy.harvard.edu b Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Boston, Massachusetts, USA Authors' Affiliations: Departments of 1Radiology and 2Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital; and 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute , Boston, MA , USA Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Radiology, Brigham and Women’s Hospital; Department of Biostatics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Department of Biostatistics & Computational Biology Dana-Farber Cancer Institute, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA 2Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. From the Division of Cardiology (M.G.-H., N.W.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Departments of Cardiology (L.B.S.), Anesthesia (M.E.K., L.B.G.), Genetics (D.T.M.), and Pediatric Oncology (M.W.K.), Children's Hospital Boston and Harvard Medical School, Boston, MA; Division of Pediatric Oncology (M.W.K.) and Department of Biostatistics and Computational Biology (A.S., A.G.-H., D.N.), Dana-Farber Cancer Institute, Boston, MA; Department of Biostatistics (A.S., D.N.... Division of Biostatistics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215; 2Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 3Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA Dana-Farber Cancer Institute, Boston, MA Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215; 4Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. 6Biostatistics & Computational Biology, Dana Farber Cancer Institute, Harvard School of Public Health, Boston, Massachusetts. 2Dana-Farber Cancer Institute, Boston, Massachusetts. Jacquie H. Chirgwin and John F. Forbes, University of Newcastle; John F. Forbes, Calvary Mater Newcastle, Newcastle; Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales; Jacquie H. Chirgwin, Box Hill Hospital; Jacquie H. Chirgwin, Maroondah Hospital; Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia; Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute;... 10Dana Farber Cancer Institute, Boston, Massachusetts. 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute , Boston, Massachusetts , USA Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA 2Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; 3Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Medical Center Hines, Illinois Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA International Breast Cancer Study Group (IBCSG), Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Authors' Affiliations: 1Departments of Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School; 3Melanoma Disease Center, Dana-Farber/Brigham and Women's Cancer Center; 4Center for Immuno-oncology, Dana-Farber Cancer Institute; and 5Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Departments of Medical Oncology and 2Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School; 3Melanoma Disease Center, Dana-Farber/Brigham and Women's Cancer Center; 4Center for Immuno-oncology, Dana-Farber Cancer Institute; and 5Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA 2Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC), Boston, Massachusetts. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA 5Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 4Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. 3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation;... 7Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. From the Departments of Neurology (N.J.U., Y.-J.C.), Hematology/Oncology (M.W.K.), Anesthesia (L.B.G., M.E.K.), Genetics (D.T.M), and Radiology (V.M.S.), Boston Children's Hospital and Harvard Medical School, Boston, MA; Department of Pediatrics (L.B.G.), Hasbro Children's Hospital and Warren Alpert Medical School of Brown University, Providence, RI; and Department of Biostatistics and Computational Biology (A.G.-H., D.N.), Dana-Farber Cancer Institute, Boston, MA. Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. 4Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts. Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology,... Dana Farber Cancer Institute, Boston, USA Dana-Farber Cancer Institute, Boston, Massachusetts, USA; 2Biostatistics, and All authors: Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; and Richard D. Gelber, Harvard School of Public Health, Boston, MA. Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 3Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. From the European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health; Frontier Science and Technology Research Foundation; Harvard Medical School, Boston, MA; Breast Center, Kantonsspital, St Gallen; International Breast Cancer Study Group, Swiss Group for Clinical Cancer Research, Bern; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Danish Breast Cancer Cooperative Group,... Biostatistics and Computational Biology |
Incoming Links
Total number of triples: 234.